Search results
Ascidian and Roche to develop RNA therapies for neurological diseases
Pharmaceutical Technology via Yahoo Finance· 20 hours agoThe technology preserves natural gene expression patterns and levels. Ascidian Therapeutics...
ReviR Therapeutics Reaches Milestone in Novel Splicing Therapy Development in Collaboration with...
Morningstar· 3 days agoThe joint effort to develop treatments for cancers using a novel target has resulted in the successful identification of a new lead series of small molecules that modulate ...
Gateway - Quartz
Quartz· 1 day agoJohnson’s latest foray into anti-aging science took him to the Roatan, an island off the coast of Honduras, where he received follistatin gene therapy in ...
Sanofi taps Belharra for immune drug research; AstraZeneca’s new cancer drug falls short
BioPharma Dive via Yahoo Finance· 2 days agoBelharra will use its chemoproteomics technology to identify immune drugs for Sanofi. Elsewhere,...
Lung-targeted CRISPR therapy offers hope for cystic fibrosis
New Scientist· 7 days agoA CRISPR gene-editing therapy has the potential to offer an effective, long-lasting treatment for...
Colorectal cancer: How Metformin could help slow cancer cell growth
Medical News Today· 6 days ago“In this particular study, there is some suggestion that metformin may play a role in the...
Thermo Fisher's (TMO) New Launch Supports Full Lab Automation
Zacks via Yahoo Finance· 6 days agoCO2 incubators are being used extensively in cancer research, stem cell research, tissue...
Charles River (CRL) Advances in T-Cell Therapy With New Alliance
Zacks· 2 days agoPer the terms of the agreement, Captain T Cell will leverage Charles River’s established plasmid and...
Study discovers 'trigger gene' in IBD as researchers look for drugs to prevent the bowel disease
Fox News· 3 days agoNow, researchers at the U.K.’s Francis Crick Institute, working with UCL and Imperial College...
Ultragenyx seeks $350M, rare accelerated approval for rare disease gene therapy - San Francisco...
The Business Journals· 6 days agoUltragenyx Pharmaceutical Inc. hopes to sell up to $350 million in stock and pre-funded warrants as...
